Exact Mass: 760.2883

Exact Mass Matches: 760.2883

Found 46 metabolites which its exact mass value is equals to given mass value 760.2883, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mono(glucosyluronic acid)bilirubin

(2S,3S,4S,5R,6S)-6-{[3-(2-{[3-(2-carboxyethyl)-5-{[(2E)-4-ethenyl-5-hydroxy-3-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-5-hydroxy-4-methyl-2H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2956)


This compound belongs to the family of Tricarboxylic Acids and Derivatives. These are organic compounds containing three carboxylic acid groups (or salt/ester derivatives thereof).

   

Albanin G

8-{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)-4H-chromen-4-one

C45H44O11 (760.2883)


Albanin G is found in fruits. Albanin G is a constituent of white mulberry (Morus alba) Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1]. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1].

   

Bilirubin glucuronide

(2S,3S,4S,5R,6R)-5-{[3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoyl]oxy}-3,4,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2956)


Bilirubin glucuronide is a natural human metabolite of bilirubin generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Bilirubin glucuronide is a natural human metabolite of bilirubin generated in the liver by UDP glucuonyltransferase.

   

KuwanonH

4H-1-Benzopyran-4-one, 8-(6-(2,4-dihydroxy-3-(3-methyl-2-butenyl )benzoyl)-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-butenyl)-, (1S-(1alpha,5alpha,6beta))-

C45H44O11 (760.2883)


Kuwanone H is a tetrahydroxyflavone isolated from the plant species of the genus Morus. It has a role as a plant metabolite. It is a tetrahydroxyflavone and a member of resorcinols. Kuwanon H is a natural product found in Morus nigra and Bos taurus with data available. A tetrahydroxyflavone isolated from the plant species of the genus Morus. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1]. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1].

   

SCHEMBL16362653

SCHEMBL16362653

C45H44O11 (760.2883)


   

Fokienagarofuran D

(+)-Fokienagarofuran D

C45H44O11 (760.2883)


   

SCHEMBL16362754

SCHEMBL16362754

C45H44O11 (760.2883)


   

SCHEMBL16362998

SCHEMBL16362998

C45H44O11 (760.2883)


   

Caeruleoside A

Caeruleoside A

C34H48O19 (760.279)


   

1,2,8,9-Tetrabenzoyl,6-Ac-1,2,6,8,9-Pentahydroxydihydro-beta-agarofuran|Triptogelin A-1

1,2,8,9-Tetrabenzoyl,6-Ac-1,2,6,8,9-Pentahydroxydihydro-beta-agarofuran|Triptogelin A-1

C45H44O11 (760.2883)


   
   

(?)-(7S,8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-7,9,9-triol 7,9-bis-O-beta-D-glucopyranoside|syringylglycerol-8-O-4-sinapyl alcohol ether beta-diglucopyranoside

(?)-(7S,8R,7E)-4-hydroxy-3,3,5,5-tetramethoxy-8,4-oxyneolign-7-ene-7,9,9-triol 7,9-bis-O-beta-D-glucopyranoside|syringylglycerol-8-O-4-sinapyl alcohol ether beta-diglucopyranoside

C34H48O19 (760.279)


   
   

C12-beta-glucuronosyl-bilirubin-IX alpha

C12-beta-glucuronosyl-bilirubin-IX alpha

C39H44N4O12 (760.2956)


   

C8-beta-glucuronosyl-bilirubin-IX alpha

C8-beta-glucuronosyl-bilirubin-IX alpha

C39H44N4O12 (760.2956)


   

Galα1-3Galβ1-4[Fucα1-3]GlcNAcβ-Sp

Galα1-3Galβ1-4[Fucα1-3]GlcNAcβ-Sp

C28H48N4O20 (760.2862)


   

GalNAcα(1-3)[Fucα(1-2)]Galβ(1-4)Glcβ-Sp

GalNAcα(1-3)[Fucα(1-2)]Galβ(1-4)Glcβ-Sp

C28H48N4O20 (760.2862)


   

Galα(1-3)[Fucα(1-2)]Galβ(1-4)GlcNAcβ-Sp

Galα(1-3)[Fucα(1-2)]Galβ(1-4)GlcNAcβ-Sp

C28H48N4O20 (760.2862)


   

Bilirubin glucuronate

mono-beta-delta-Glucopyranuronosyl ester 2,17-diethenyl-1,10-19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid

C39H44N4O12 (760.2956)


   

Gala1-3[Fuca1-2]Galb1-3GlcNAcb-Sp

Gala1-3[Fuca1-2]Galb1-3GlcNAcb-Sp

C28H48N4O20 (760.2862)


   

taccalonolide AA

taccalonolide AA

C38H48O16 (760.2942)


   

Kuwanon H

4H-1-Benzopyran-4-one, 8-(6-(2,4-dihydroxy-3-(3-methyl-2-butenyl )benzoyl)-5-(2,4-dihydroxyphenyl)-3-methyl-2-cyclohexen-1-yl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methyl-2-butenyl)-, (1S-(1alpha,5alpha,6beta))-

C45H44O11 (760.2883)


Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1]. Kuwanon H is a flavonoid isolated from Morus alba, which acts as a potent non-peptide bombesin receptor antagonist. Kuwanon H selectively inhibits binding of gastrin releasing peptide CRP to GRP-preferring recepotr, with a Ki value of 290 nM in cells[1].

   

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2956)


   

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-4-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,5,6-trihydroxyoxane-2-carboxylic acid

C39H44N4O12 (760.2956)


   

mono(glucosyluronic acid)bilirubin

mono(glucosyluronic acid)bilirubin

C39H44N4O12 (760.2956)


   

2-(2,4-dihydroxyphenyl)-8-[(1r,5s,6s)-6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

2-(2,4-dihydroxyphenyl)-8-[(1r,5s,6s)-6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883)


   

methyl 4-[(7,8-dihydroxy-6-{[6-hydroxy-4-(methoxycarbonyl)-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-2-yl)methyl]-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

methyl 4-[(7,8-dihydroxy-6-{[6-hydroxy-4-(methoxycarbonyl)-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-2-yl)methyl]-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C34H48O19 (760.279)


   

(1s,2r,4s,5r,6r,7s,9r,12s)-5-(acetyloxy)-7,12-bis(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

(1s,2r,4s,5r,6r,7s,9r,12s)-5-(acetyloxy)-7,12-bis(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

C45H44O11 (760.2883)


   

(7r,8r,10s)-10-{[(2r,4s,5s,6s)-5-{[(2s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

(7r,8r,10s)-10-{[(2r,4s,5s,6s)-5-{[(2s,5s,6s)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

C38H48O16 (760.2942)


   

(2r,4s,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

(2r,4s,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C45H44O11 (760.2883)


   

2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxy-phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromone

2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxyphenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one; 2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]carbonyl-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxy-phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one; 2-[3-[(1S,5R,6S)-6-[[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-oxomethyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxyphenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)-4-chromenone; 2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxy-phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one

C45H44O11 (760.2883)


{"Ingredient_id": "HBIN003814","Ingredient_name": "2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxy-phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromone","Alias": "2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxyphenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one; 2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]carbonyl-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxy-phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one; 2-[3-[(1S,5R,6S)-6-[[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-oxomethyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxyphenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)-4-chromenone; 2-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methyl-1-cyclohex-2-enyl]-2,4-dihydroxy-phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one","Ingredient_formula": "C45H44O11","Ingredient_Smile": "NA","Ingredient_weight": "760.82","OB_score": "3.013685996","CAS_id": "89200-02-2","SymMap_id": "SMIT13436","TCMID_id": "NA","TCMSP_id": "MOL012702","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1s,2r,4s,5r,6r,7s,9r,12r)-5-(acetyloxy)-7,12-bis(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

(1s,2r,4s,5r,6r,7s,9r,12r)-5-(acetyloxy)-7,12-bis(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

C45H44O11 (760.2883)


   

2-(2,4-dihydroxyphenyl)-8-[6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

2-(2,4-dihydroxyphenyl)-8-[6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883)


   

8-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

8-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883)


   

10-{[5-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

10-{[5-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,7,8,11-pentahydroxy-9,10-dihydro-7h-tetracene-5,12-dione

C38H48O16 (760.2942)


   

2-(2,4-dihydroxyphenyl)-8-[(1r,5r,6s)-6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

2-(2,4-dihydroxyphenyl)-8-[(1r,5r,6s)-6-(2,4-dihydroxyphenyl)-5-(5-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883)


   

(1r,10s)-5-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-4,6,14-trihydroxy-10-(3-methylbut-2-en-1-yl)-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-2-one

(1r,10s)-5-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-4,6,14-trihydroxy-10-(3-methylbut-2-en-1-yl)-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-2-one

C45H44O11 (760.2883)


   

(8r)-8-ethyl-1,6,7,8,11-pentahydroxy-10-{[4-hydroxy-5-({4-hydroxy-6-methyl-5-[(6-methyl-5-oxooxan-2-yl)oxy]oxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

(8r)-8-ethyl-1,6,7,8,11-pentahydroxy-10-{[4-hydroxy-5-({4-hydroxy-6-methyl-5-[(6-methyl-5-oxooxan-2-yl)oxy]oxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

C38H48O16 (760.2942)


   

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C45H44O11 (760.2883)


   

8-ethyl-1,6,7,8,11-pentahydroxy-10-{[4-hydroxy-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione

8-ethyl-1,6,7,8,11-pentahydroxy-10-{[4-hydroxy-5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione

C38H48O16 (760.2942)


   

6-{6-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

6-{6-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883)


   

2-(3-{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

2-(3-{6-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-en-1-yl)chromen-4-one

C45H44O11 (760.2883)


   

methyl (4s,5r,6s)-4-{[(2r,4ar,6s,7r,8r,8as)-6-{[(1s,4as,6s,7r,7as)-6-hydroxy-4-(methoxycarbonyl)-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-7,8-dihydroxy-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-2-yl]methyl}-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

methyl (4s,5r,6s)-4-{[(2r,4ar,6s,7r,8r,8as)-6-{[(1s,4as,6s,7r,7as)-6-hydroxy-4-(methoxycarbonyl)-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-7,8-dihydroxy-hexahydro-2h-pyrano[3,2-d][1,3]dioxin-2-yl]methyl}-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C34H48O19 (760.279)


   

(7r,8r,10s)-8-ethyl-1,6,7,8,11-pentahydroxy-10-{[(2r,4s,5s,6s)-4-hydroxy-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione

(7r,8r,10s)-8-ethyl-1,6,7,8,11-pentahydroxy-10-{[(2r,4s,5s,6s)-4-hydroxy-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione

C38H48O16 (760.2942)


   

12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

12-(acetyloxy)-4,5,7-tris(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C45H44O11 (760.2883)